Target intelligence / Profile preview

Actin-associated LIM protein (ALP)

Target
ALP
Molecular classification
Adaptor/scaffold protein, PDZ domain-containing protein, LIM domain-containing protein, Cytoskeletal protein
01

Overview

Actin-associated LIM protein (ALP), encoded by the *PDLIM3* gene, is a cytoskeletal adaptor that contains both a PDZ domain and a LIM domain, allowing it to anchor and organize actin filaments within muscle cells[1][2][4]. ALP is highly expressed in heart and skeletal muscle, where it localizes primarily to Z-discs and intercalated discs, playing a crucial role in myofibrilogenesis and muscle fiber contractility[1]. It supports cross-linking of actin filaments by α-actinin-2 and is essential for correct cardiac chamber formation and function, as highlighted in knockout mouse models where its absence causes right ventricular malformations and cardiomyopathy. Structural studies show that ALP and other PDLIM family proteins function mainly as scaffolds linking cytoskeletal and membrane-associated proteins, thereby influencing subcellular localization and actin filament organization[2]. No direct drug-targeting or biomarker utility has been established for PDLIM3/ALP to date.

Other names
PDZ and LIM domain protein 3PDLIM3ALP
02

Biological functions

Organization of actin cytoskeletonMuscle fiber developmentScaffolding protein–protein interactionsCardiac muscle formation and contractility
03

Disease associations

Cardiomyopathy/heart muscle diseaseMuscle dysplasiaPotential involvement in genetic cardiac defects

Beyond the preview

Go deeper on Actin-associated LIM protein (ALP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin-associated LIM protein (ALP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call